Research Article
The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis
Table 1
Clinical characteristics of patients at the time of enrolment.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
vWF-Ag, von Willebrand factor antigen; BMI, body mass index; CTP, Child–Turcotte–Pugh; INR, international normalized ratio; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TB, total bilirubin; TCH, total cholesterol; UN, urea nitrogen LDH, lactic dehydrogenase; CRP, C-reactive protein; PLT, platelet count; HBV, hepatitis B virus. |